# Transgender, Silicone and Blood Smear

> **NCT02580760** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 66 (actual)

## Conditions studied

- Injection; Complications, Sepsis
- Injection Site Disorder
- Injection Site Extravasation
- Intentional Poisoning by Silicone

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02580760
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2016-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02580760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02580760, "Transgender, Silicone and Blood Smear". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02580760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*